Mereo BioPharma (MREO) Other Operating Expenses (2024 - 2026)
Mereo BioPharma (MREO) reported Other Operating Expenses of $2.0 million for Q1 2026, up 221.48% year-over-year from $636735.3 in Q1 2025, and down 37.8% quarter-over-quarter from $3.3 million in Q3 2025.
Mereo BioPharma (MREO) Other Operating Expenses (2024 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 3 years of Other Operating Expenses data on file, last reported at $2.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | -1.69 Mn |
| Sep 30, 2024 | -5.63 Mn |